The hallucinatory drug PCP (phencyclidine)
a. is an antagonist of the NMDA receptor.
b. facilitates the binding of glutamate to the AMPA receptor.
c. releases serotonin from neurons in the raphe nuclei.
d. inhibits the dendrites of dopamine neurons in the ventral tegmental area.
e. acts via the blockade of serotonin receptors.
Question 2
Which of the following is true of NMDA receptors?
a. Activation of the NMDA receptor allows sodium and calcium ions to flow into the nerve cell.
b. NMDA receptors are metabotropic.
c. NMDA receptors are the most common glutamate receptor.
d. The activity of the NMDA receptor is not dependent on magnesium ions.
e. The NMDA receptor produces IPSPs.
The T-cell receptor and antigen presentations.
Sample tiered drug formulary for antibiotics.
Organization of the Food and Drug Administration showing the seven centers that regulate human and ...
Teaching women about the safety of drug use during pregnancy is an essential component of nursing ...
Clinically Significant Drug-Disease Interactions in Dentistry
The nicotinic acetylcholine receptor